A detailed history of Adar1 Capital Management, LLC transactions in Geron Corp stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 557,159 shares of GERN stock, worth $1.86 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
557,159
Previous 90,000 519.07%
Holding current value
$1.86 Million
Previous $382 Million 562.87%
% of portfolio
0.41%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.17 - $4.99 $1.95 Million - $2.33 Million
467,159 Added 519.07%
557,159 $2.53 Billion
Q2 2024

Aug 13, 2024

BUY
$3.1 - $5.09 $274,985 - $451,508
88,705 Added 6849.81%
90,000 $382 Million
Q1 2024

May 15, 2024

SELL
$1.75 - $3.44 $28,000 - $55,040
-16,000 Reduced 92.51%
1,295 $4.27 Million
Q4 2023

Feb 14, 2024

BUY
$1.74 - $2.31 $30,093 - $39,951
17,295 New
17,295 $36.5 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.26B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.